Please Wait.....
Report
Global Travel Vaccine Market - Industry Trends and Forecast to 2031
Market Report I 2024-03-01 I 493 Pages I Data Bridge Market Research
Global travel vaccine market is expected to reach USD 13,087,835.81 thousand by 2032 from USD 6,144,158.80 thousand in 2023, growing at a substantial CAGR of 8.9% in the forecast period of 2024 to 2032.
Market Segmentation:
Global travel vaccines market, By Composition (Combination Vaccines and Mono Vaccines), Type (Inactivated Vaccines, Subunit, Recombinant, Polysaccharide and Conjugate Vaccines, Live-Attenuated Vaccines, Toxoid Vaccines, DNA Vaccines, and Viral Vector Vaccines), Category (Recommended Vaccine, Routine Vaccine, and Required Vaccine), Disease (Typhoid, Hepatitis, Cholera, Varicella, Influenza, Japanese Encephalitis, Meningococcal Meningitis, Yellow Fever, Rabies, DPT, Measles and Mumps, Tick-Borne Encephalitis, Malaria, Covid-19, Polio, and Others), Route of Administration (Injectable and Oral), Gender (Male and Female), Patient Type (Adult, Pediatric, and Geriatric), Age Group (20-50 Years, Less than 20 Years, and Above 50 Years), Distribution Channel (B2B and B2C), Countries (U.S., Canada, Mexico, Germany, U.K., France, Italy, Netherlands, Spain, Russia, Switzerland, Poland, Norway, Hungary, Austria, Ireland, Lithuania, Rest of Europe, China, Japan, India, South Korea, Australia, Singapore, Thailand, Indonesia, Malaysia, Philippines, Vietnam, Rest of Asia-Pacific, Brazil, Argentina, Peru, Rest of South America, Saudi Arabia, U.A.E., Israel, South Africa, Egypt, Kuwait, and Rest of Middle East and Africa) - Industry Trends and Forecast to 2032
Some of the major factors contributing to the growth of the global travel vaccines market are:
Driver
- Rising incidence of infectious diseases
Restraint
- High cost of travel vaccines
Opportunity
- Advancements in vaccine technology
Market Players
Some major companies dealing in the global travel vaccines market are:
- GSK plc.
- Bavarian Nordic
- Pfizer Inc.
- Abbott
- CSL
- AstraZeneca
- Sanofi
- Merck & Co., Inc.
- Valneva SE
- Johnson & Johnson Services Inc.
- Dynavax Technologies.
TABLE OF CONTENTS
1 INTRODUCTION 51
1.1 OBJECTIVES OF THE STUDY 51
1.2 MARKET DEFINITION 51
1.3 OVERVIEW OF GLOBAL TRAVEL VACCINES MARKET 51
1.4 LIMITATIONS 53
1.5 MARKETS COVERED 53
2 MARKET SEGMENTATION 57
2.1 MARKETS COVERED 57
2.2 GEOGRAPHICAL SCOPE 58
2.3 YEARS CONSIDERED FOR THE STUDY 59
2.4 CURRENCY AND PRICING 59
2.5 DBMR TRIPOD DATA VALIDATION MODEL 60
2.6 MULTIVARIATE MODELLING 63
2.7 PRODUCT TYPE LIFELINE CURVE 63
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 64
2.9 DBMR MARKET POSITION GRID 65
2.10 MARKET APPLICATION COVERAGE GRID 66
2.11 VENDOR SHARE ANALYSIS 67
2.12 SECONDARY SOURCES 68
2.13 ASSUMPTIONS 68
3 EXECUTIVE SUMMARY 69
4 PREMIUM INSIGHTS 72
4.1 PESTEL ANALYSIS 75
4.2 PORTER'S FIVE FORCES 76
4.3 PIPELINE ANALYSIS 77
5 MARKET OVERVIEW 81
5.1 DRIVERS 83
5.1.1 RISING INCIDENCE OF INFECTIOUS DISEASES 83
5.1.2 INCREASING TRAVEL AND TOURISM 85
5.1.3 GOVERNMENT REGULATIONS AND RECOMMENDATIONS REGARDING VACCINATION 86
5.1.4 EXPANSION OF TRAVEL MEDICINE CLINICS 86
5.2 RESTRAINTS 87
5.2.1 HIGH COST OF TRAVEL VACCINES 87
5.2.2 REGULATORY HURDLES FOR APPROVAL 88
?
5.3 OPPORTUNITIES 88
5.3.1 ADVANCEMENTS IN VACCINE TECHNOLOGY 88
5.3.2 GROWING AWARENESS REGARDING VACCINES 89
5.3.3 INTEGRATION OF DIGITAL HEALTH SOLUTIONS 89
5.4 CHALLENGES 90
5.4.1 COLD CHAIN REQUIREMENTS FOR STORAGE 90
5.4.2 VACCINE HESITANCY AND MISINFORMATION 91
6 GLOBAL TRAVEL VACCINE MARKET, BY COMPOSITION 92
6.1 OVERVIEW 93
6.2 COMBINATION VACCINES 96
6.3 MONO VACCINES 96
7 GLOBAL TRAVEL VACCINE MARKET, BY TYPE 97
7.1 OVERVIEW 98
7.2 INACTIVATED VACCINES 101
7.2.1 HEPATITIS A 102
7.2.2 INFLUENZA 102
7.2.3 RABIES 102
7.2.4 TICK-BORNE ENCEPHALITIS 102
7.2.5 JAPANESE ENCEPHALITIS 102
7.2.6 POLIO 103
7.3 SUBUNIT, RECOMBINANT, POLYSACCHARIDE AND CONJUGATE VACCINES 103
7.3.1 HEPATITIS B 104
7.3.2 MENINGOCOCCAL 104
7.3.3 MALARIA 104
7.3.4 COVID-19 104
7.4 LIVE-ATTENUATED VACCINES 105
7.4.1 TYPHOID 106
7.4.2 CHOLERA 106
7.4.3 YELLOW FEVER 106
7.4.4 MEASLES 106
7.4.5 MUMPS 107
7.4.6 RUBELLA 107
7.4.7 VARICELLA 107
7.4.8 OTHERS 107
7.5 TOXOID VACCINES 107
7.5.1 DIPHTHERIA 108
7.5.2 TETANUS 108
7.6 DNA VACCINES 108
7.7 VIRAL VECTOR VACCINES 109
8 GLOBAL TRAVEL VACCINE MARKET, BY CATEGORY 110
8.1 OVERVIEW 111
8.2 RECOMMENDED VACCINE 114
8.2.1 TYPHOID FEVER VACCINES 115
8.2.2 HEPATITIS A 115
8.2.3 CHOLERA 115
8.2.4 RABIES 115
8.2.5 TICK-BORNE ENCEPHALITIS 115
8.2.6 JAPANESE ENCEPHALITIS 115
8.2.7 MALARIA 115
8.2.8 OTHERS 115
8.3 ROUTINE VACCINE 116
8.3.1 HEPATITIS B 117
8.3.2 INFLUENZA VACCINES 117
8.3.3 PNEUMOCOCCAL 117
8.3.4 DIPHTHERIA 117
8.3.5 TETANUS 117
8.3.6 MEASLES 117
8.3.7 MUMPS 117
8.3.8 RUBELLA 117
8.3.9 PERTUSSIS 117
8.3.10 OTHERS 118
8.4 REQUIRED VACCINE 118
8.4.1 YELLOW FEVER 119
8.4.2 MENINGOCOCCAL 119
8.4.3 POLIO VACCINES 119
9 GLOBAL TRAVEL VACCINE MARKET, BY DISEASE 120
9.1 OVERVIEW 121
9.2 TYPHOID 125
9.3 HEPATITIS 125
9.3.1 HEPATITIS A 126
9.3.2 HEPATITIS B 126
9.4 CHOLERA 126
9.5 VARICELLA 127
9.6 INFLUENZA 127
9.7 JAPANESE ENCEPHALITIS 128
9.8 MENINGOCOCCAL MENINGITIS 128
9.9 YELLOW FEVER 129
9.10 RABIES 129
9.11 DPT 130
9.12 MEASLES AND MUMPS 130
9.13 TICK-BORNE ENCEPHALITIS 131
9.14 MALARIA 131
9.15 COVID-19 132
9.16 POLIO 132
9.17 OTHERS 133
10 GLOBAL TRAVEL VACCINE MARKET, BY ROUTE OF ADMINISTRATION 134
10.1 OVERVIEW 135
10.2 INJECTABLE 138
10.2.1 INTRAMUSCULAR 139
10.2.2 SUBCUTANEOUS 139
10.2.3 OTHERS 139
10.3 ORAL 139
11 GLOBAL TRAVEL VACCINE MARKET, BY GENDER 140
11.1 OVERVIEW 141
11.2 MALE 144
11.3 FEMALE 144
12 GLOBAL TRAVEL VACCINE MARKET, BY PATIENT TYPE 145
12.1 OVERVIEW 146
12.2 ADULT 149
12.3 PEDIATRIC 149
12.4 GERIATRIC 150
13 GLOBAL TRAVEL VACCINE MARKET, BY AGE GROUP 151
13.1 OVERVIEW 152
13.2 20-50 YEARS 155
13.3 LESS THAN 20 YEARS 156
13.4 ABOVE 50 YEARS 157
14 GLOBAL TRAVEL VACCINE MARKET, BY DISTRIBUTION CHANNEL 158
14.1 OVERVIEW 159
14.2 B2B 162
14.3 B2C 162
?
15 GLOBAL TRAVEL VACCINE MARKET, BY REGION 163
15.1 OVERVIEW 164
15.2 NORTH AMERICA 168
15.2.1 U.S. 176
15.2.2 CANADA 183
15.2.3 MEXICO 191
15.3 ASIA-PACIFIC 198
15.3.1 INDIA 206
15.3.2 CHINA 213
15.3.3 MALAYSIA 220
15.3.4 SOUTH KOREA 228
15.3.5 JAPAN 235
15.3.6 AUSTRALIA 242
15.3.7 THAILAND 250
15.3.8 VIETNAM 257
15.3.9 SINGAPORE 264
15.3.10 INDONESIA 271
15.3.11 PHILIPPINES 278
15.3.12 REST OF ASIA-PACIFIC 285
15.4 EUROPE 286
15.4.1 GERMANY 294
15.4.2 U.K. 300
15.4.3 FRANCE 306
15.4.4 RUSSIA 312
15.4.5 ITALY 318
15.4.6 SPAIN 324
15.4.7 POLAND 330
15.4.8 NETHERLANDS 336
15.4.9 SWITZERLAND 342
15.4.10 HUNGARY 348
15.4.11 AUSTRIA 353
15.4.12 IRELAND 359
15.4.13 NORWAY 364
15.4.14 LITHUANIA 369
15.4.15 REST OF EUROPE 374
?
15.5 MIDDLE EAST AND AFRICA 375
15.5.1 SAUDI ARABIA 383
15.5.2 EGYPT 389
15.5.3 SOUTH AFRICA 395
15.5.4 KUWAIT 400
15.5.5 U.A.E. 405
15.5.6 ISRAEL 411
15.5.7 REST OF MIDDLE EAST AND AFRICA 416
15.6 SOUTH AMERICA 417
15.6.1 ARGENTINA 424
15.6.2 BRAZIL 431
15.6.3 PERU 437
15.6.4 REST OF SOUTH AMERICA 443
16 GLOBAL TRAVEL VACCINE MARKET: COMPANY LANDSCAPE 444
16.1 COMPANY SHARE ANALYSIS: GLOBAL 444
16.2 COMPANY SHARE ANALYSIS: NORTH AMERICA 445
16.3 COMPANY SHARE ANALYSIS: EUROPE 446
16.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC 447
17 SWOT ANALYSIS 448
18 COMPANY PROFILE 449
18.1 PFIZER INC. 449
18.1.1 COMPANY SNAPSHOT 449
18.1.2 REVENUE ANALYSIS 449
18.1.3 COMPANY SHARE ANALYSIS 450
18.1.4 PRODUCT PORTFOLIO 450
18.1.5 RECENT DEVELOPMENT 451
18.2 SANOFI 452
18.2.1 COMPANY SNAPSHOT 452
18.2.2 REVENUE ANALYSIS 452
18.2.3 COMPANY SHARE ANALYSIS 453
18.2.4 PRODUCT PORTFOLIO 453
18.2.5 RECENT DEVELOPMENT 457
18.3 JOHNSON & JOHNSON SERVICES INC. 458
18.3.1 COMPANY SNAPSHOT 458
18.3.2 REVENUE ANALYSIS 458
18.3.3 COMPANY SHARE ANALYSIS 459
18.3.4 PRODUCT PORTFOLIO 459
18.3.5 RECENT DEVELOPMENTS 460
18.4 GSK PLC. 461
18.4.1 COMPANY SNAPSHOT 461
18.4.2 REVENUE ANALYSIS 461
18.4.3 COMPANY SHARE ANALYSIS 462
18.4.4 PRODUCT PORTFOLIO 462
18.4.5 RECENT DEVELOPMENT 467
18.5 MERCK & CO., INC. 469
18.5.1 COMPANY SNAPSHOT 469
18.5.2 REVENUE ANALYSIS 469
18.5.3 COMPANY SHARE ANALYSIS 470
18.5.4 PRODUCT PORTFOLIO 470
18.5.5 RECENT DEVELOPMENT 472
18.6 ABBOTT 473
18.6.1 COMPANY SNAPSHOT 473
18.6.2 REVENUE ANALYSIS 473
18.6.3 PRODUCT PORTFOLIO 474
18.6.4 RECENT DEVELOPMENT 475
18.7 ASTRAZENECA 476
18.7.1 COMPANY SNAPSHOT 476
18.7.2 REVENUE ANALYSIS 476
18.7.3 PRODUCT PORTFOLIO 477
18.7.4 RECENT DEVELOPMENT 477
18.8 BAVARIAN NORDIC 479
18.8.1 COMPANY SNAPSHOT 479
18.8.2 REVENUE ANALYSIS 479
18.8.3 PRODUCT PORTFOLIO 480
18.8.4 RECENT DEVELOPMENT 480
18.9 CSL 482
18.9.1 COMPANY SNAPSHOT 482
18.9.2 REVENUE ANALYSIS 482
18.9.3 PRODUCT PORTFOLIO 483
18.9.4 RECENT DEVELOPMENT 484
18.10 DYNAVAX TECHNOLOGIES. 485
18.10.1 COMPANY SNAPSHOT 485
18.10.2 REVENUE ANALYSIS 485
18.10.3 PRODUCT PORTFOLIO 486
18.10.4 RECENT DEVELOPMENTS 486?
18.11 VALNEVA SE 487
18.11.1 COMPANY SNAPSHOT 487
18.11.2 REVENUE ANALYSIS 487
18.11.3 PRODUCT PORTFOLIO 488
18.11.4 RECENT DEVELOPMENT 488
19 QUESTIONNAIRE 489
20 RELATED REPORTS 493
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security